GlassScriptPhysician profile
Madonna A Biritwum
NPI 1295975779
$3,831.22
in general payments reported to CMS, 2019-2025
18 companies · $1,050 in 2025
The $1,050 reported for 2025 was more than what 79% of Infectious Disease providers received nationally (typical 2025 total: $187).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $23.53 · 2020: $12.70 · 2022: $380 · 2023: $1,092 · 2024: $1,273 · 2025: $1,050.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,415.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,414.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $787.31 | 2022-2025 | Veklury, Biktarvy |
| Viiv Healthcare Company | $607.09 | 2022-2025 | Cabenuva, Dovato, Apretude |
| Abbvie INC. | $467.95 | 2023-2025 | Mavyret, Teflaro, Avycaz |
| Merck Sharp & Dohme LLC | $348.82 | 2019-2025 | Pifeltro, Dificid, Delstrigo |
| Insmed, INC. | $340.95 | 2022-2025 | Arikayce |
| Shionogi INC | $255.19 | 2022-2025 | Fetroja |
| Melinta Therapeutics, LLC | $242.64 | 2019-2025 | Orbactiv, Kimyrsa, Rezzayo |
| Aimmune Therapeutics, INC. | $193.45 | 2024-2025 | Zenpep, Vowst |
| Paratek Pharmaceuticals, INC. | $155.79 | 2022-2025 | Nuzyra |
| La Jolla Pharmaceutical Company | $139.08 | 2023-2025 | Xacduro, Zevtera, Xerava |
| Cumberland Pharmaceuticals, INC. | $61.05 | 2023 | Vibativ |
| Ferring Pharmaceuticals INC. | $59.00 | 2022-2024 | Rebyota |
| Janssen Biotech, INC. | $43.90 | 2023 | Symtuza |
| Roche Diagnostics Corporation | $36.72 | 2024 | Eplex |
| Modernatx, INC. | $28.55 | 2023 | Moderna Covid-19 Vaccine |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Theratechnologies INC. | $27.27 | 2023 | Egrifta, Trogarzo |
| Philips North America LLC | $19.99 | 2025 | Vest Therapy Und |
| Astellas Pharma US INC | $16.47 | 2023 | Cresemba |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Madonna Biritwum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.